- Relief Therapeutics Announces Executive Changes
- Relief Therapeutics Announces Notice of Annual General Meeting of Shareholders
- Relief Therapeutics Announces New Executive Leadership Team strengthening capabilities to guide the Company through pipeline development initiatives
- Relief Therapeutics has published its Annual Report
- RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting
- RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting
- Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
More ▼
Key statistics
On Friday, Relief Therapeutics Holding SA (RLF:SWX) closed at 1.20, 4.35% above its 52-week low of 1.15, set on May 03, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.21 |
---|---|
High | 1.25 |
Low | 1.17 |
Bid | 1.17 |
Offer | 1.22 |
Previous close | 1.25 |
Average volume | 8.47k |
---|---|
Shares outstanding | 14.04m |
Free float | 10.75m |
P/E (TTM) | -- |
Market cap | 17.55m CHF |
EPS (TTM) | -8.45 CHF |
Data delayed at least 15 minutes, as of Jun 07 2024 15:26 BST.
More ▼